Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of Resistance in Preclinical Models

/in ,

Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models